Ankit Mahadevia

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Maegan Deare, Attorney-in-Fact for Ankit Mahadevia
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ankit Mahadevia:

Company Role Class Num Shares Value Price $ Report Date Ownership
Spero Therapeutics, Inc. Director Common Stock 703,294 $1,385,489 $1.97 28 Aug 2025 Direct

Insider Reports Filed by Ankit Mahadevia

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SPRO Spero Therapeutics, Inc. 28 Aug 2025 1 -$12,947 4 Director 03 Sep 2025, 06:04
SPRO Spero Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 20:32
SPRO Spero Therapeutics, Inc. 05 Feb 2025 2 -$53,991 4 Director 05 Feb 2025, 20:30
SPRO Spero Therapeutics, Inc. 27 Aug 2024 1 -$7,981 4 Director 29 Aug 2024, 18:43
SPRO Spero Therapeutics, Inc. 29 May 2024 1 $0 4 Director 30 May 2024, 16:25
SPRO Spero Therapeutics, Inc. 02 Feb 2024 1 -$87,399 4 Director 05 Feb 2024, 20:50
SPRO Spero Therapeutics, Inc. 05 Oct 2023 1 $0 4 Director 10 Oct 2023, 17:18
SPRO Spero Therapeutics, Inc. 28 Aug 2023 1 -$11,390 4 Director 30 Aug 2023, 17:21
SPRO Spero Therapeutics, Inc. 03 Feb 2023 1 -$22,238 4 CEO and President, Director 06 Feb 2023, 15:15
SPRO Spero Therapeutics, Inc. 01 Feb 2023 1 $0 4 CEO and President, Director 03 Feb 2023, 18:38
SPRO Spero Therapeutics, Inc. 01 Feb 2022 2 $0 4 CEO and President, Director 03 Feb 2022, 15:18
SPRO Spero Therapeutics, Inc. 27 Dec 2021 3 -$69,466 4 CEO and President, Director 29 Dec 2021, 17:26
SPRO Spero Therapeutics, Inc. 26 Aug 2021 1 $0 4 CEO and President, Director 30 Aug 2021, 16:15